GT Biopharma, Inc. (GTBP) Shareholders’ equity 2016–2020
GT Biopharma, Inc. (GTBP) shareholders’ equity at each fiscal year-end, per SEC filings.
-$29.4MFY2020 · since FY2016: -$18.9M → -$29.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -$29.4M | -52.4% |
| FY2019 | -$19.3M | — |
| FY2017 | $251.7M | +1430.0% |
| FY2016 | -$18.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice